Table 2.
MICs, in mg/L, for initial isolates and control H37Rv
| Drug | Initial isolates, n = 153 |
Control H37Rv, n = 25 | ||
|---|---|---|---|---|
| MIC50 | MIC90 | MIC range | MIC90 (MIC range) | |
| Trimethoprim/sulfamethoxazolea | 0.2/4 | 0.4/8 | 0.05/1–1.7/32 | 0.2/4 (0.1/2–0.4/8) |
| Mefloquine | 8 | 8 | 1–16 | 8 (4–8) |
| Thioridazine | 4 | 8 | <1–8 | 8 (4–8) |
| Clofazimine | 0.25 | 0.5 | <0.03–2 | 0.25 (0.125–0.5) |
| Amoxicillin/clavulanate | 16/8 | 32/16 | <0.5/0.25 to >64/32 | 32/16 (16/8–32/16) |
| Meropenem/clavulanate | 1/2.5 | 8/2.5 | <0.12/2.5 to >16/2.5 | 2/2.5 (2/2.5–4/2.5) |
| Nitazoxanide | 16 | 16 | <1–64 | 16 (8–32) |
| Linezolid | 0.25 | 0.25 | <0.06–0.5 | 0.5 (0.25–0.5) |
| Oxyphenbutazoneb | 40 | 60 | 20 to >80 | 60 (40–90) |
| Isoniazidb | 4 | >4 | <0.03 to >4 | <0.03 (<0.03–0.06) |
a
A total of 150 isolates had valid results for trimethoprim/sulfamethoxazole.
b
A total of 152 isolates had valid results for oxyphenbutazone and isoniazid.